{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:56:35Z","timestamp":1758970595410},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T00:00:00Z","timestamp":1518739200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00392-018-1209-3","type":"journal-article","created":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T11:57:14Z","timestamp":1518782234000},"page":"479-486","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Risk marker profiles in patients treated with percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy"],"prefix":"10.1007","volume":"107","author":[{"given":"Amelie","family":"Burghardt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"van Buuren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zisis","family":"Dimitriadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Gr\u00fcbbel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hubert","family":"Seggewiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smita","family":"Scholtz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter","family":"Horstkotte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lothar","family":"Faber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,16]]},"reference":[{"key":"1209_CR1","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0140-6736(95)91267-3","volume":"346","author":"U Sigwart","year":"1995","unstructured":"Sigwart U (1995) Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 346:211\u2013214","journal-title":"Lancet"},{"key":"1209_CR2","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1161\/01.CIR.95.8.1981","volume":"95","author":"E Braunwald","year":"1997","unstructured":"Braunwald E (1997) Induced septal infarction: a new therapeutic strategy for hypertrophic obstructive cardiomyopathy. Circulation 95:1981\u20131982","journal-title":"Circulation"},{"key":"1209_CR3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1161\/01.CIR.52.1.88","volume":"52","author":"AG Morrow","year":"1975","unstructured":"Morrow AG, Reitz BA, Epstein SE, Henry WL, Conkle DM, Itscoitz SB, Redwood DR (1975) Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients. Circulation 52:88\u2013102","journal-title":"Circulation"},{"issue":"Suppl F","key":"1209_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/eurheartj\/4.suppl_F.175","volume":"4","author":"BJ Maron","year":"1983","unstructured":"Maron BJ, Epstein SE, Morrow AG (1983) Symptomatic status and prognosis of patients after operation for hypertrophic obstructive cardiomyopathy: efficacy of ventricular septal myotomy and myectomy. Eur Heart J 4(Suppl F):175\u2013185","journal-title":"Eur Heart J"},{"key":"1209_CR5","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.jacc.2005.02.090","volume":"46","author":"SR Ommen","year":"2005","unstructured":"Ommen SR, Maron BJ, Olivotto I, Maron MS, Cecchi F, Betocchi S, Gersh BJ, Ackerman MJ, McCully RB, Dearani JA, Schaff HV, Danielson GK, Tajik AJ, Nishimura RA (2005) Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 46:470\u2013476","journal-title":"J Am Coll Cardiol"},{"key":"1209_CR6","first-page":"1940","volume":"125","author":"HD Schulte","year":"1995","unstructured":"Schulte HD, Gramsch-Zabel H, Schwartzkopff B (1995) Hypertrophische obstruktive Kardiomyopathie: Chirurgische Behandlung. Schweiz Med Wochenschr 125:1940\u20131949","journal-title":"Schweiz Med Wochenschr"},{"key":"1209_CR7","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.jacc.2005.05.013","volume":"46","author":"H Watkins","year":"2005","unstructured":"Watkins H, McKenna WJ (2005) The prognostic impact of septal myectomy in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 46:477\u2013479","journal-title":"J Am Coll Cardiol"},{"key":"1209_CR8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1161\/CIRCINTERVENTIONS.109.916676","volume":"3","author":"RA Leonardi","year":"2010","unstructured":"Leonardi RA, Kransdorf EP, Simel DL, Wang A (2010) Meta-analyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy: comparative rates of overall mortality and sudden cardiac death after treatment. Circ Cardiovasc Interv 3:97\u2013104","journal-title":"Circ Cardiovasc Interv"},{"key":"1209_CR9","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/S0735-1097(01)01614-X","volume":"38","author":"SF Nagueh","year":"2001","unstructured":"Nagueh SF, Ommen SR, Lakkis NM, Killip D, Zoghbi WA, Schaff HV, Danielson GK, Qui\u00f1ones MA, Tajik AJ, Spencer WH (2001) Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 38:1701\u20131706","journal-title":"J Am Coll Cardiol"},{"key":"1209_CR10","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jacc.2009.09.047","volume":"55","author":"S Agarwal","year":"2010","unstructured":"Agarwal S, Tuzcu EM, Desai MY, Smedira N, Lever HM, Lytle BW, Kapadia SR (2010) Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy. J Am Coll Cardiol 55:823\u2013834","journal-title":"J Am Coll Cardiol"},{"key":"1209_CR11","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1007\/s00392-007-0579-8","volume":"96","author":"H Seggewiss","year":"2007","unstructured":"Seggewiss H, Rigopoulos A, Welge D, Ziemssen P, Faber L (2007) Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy. Clin Res Cardiol 96:856\u2013863","journal-title":"Clin Res Cardiol"},{"key":"1209_CR12","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s00392-016-1005-x","volume":"105","author":"AG Rigopoulos","year":"2016","unstructured":"Rigopoulos AG, Daci S, Pfeiffer B, Papadopoulou K, Neugebauer A, Seggewiss H (2016) Low occurrence of ventricular arrhythmias after alcohol septal ablation in high-risk patients with hypertrophic obstructive cardiomyopathy. Clin Res Cardiol 105:953\u2013961","journal-title":"Clin Res Cardiol"},{"key":"1209_CR13","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1007\/s00392-007-0578-9","volume":"96","author":"L Faber","year":"2007","unstructured":"Faber L, Welge D, Fassbender D, Schmidt HK, Horstkotte D, Seggewiss H (2007) One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical response. Clin Res Cardiol 96:864\u2013873","journal-title":"Clin Res Cardiol"},{"key":"1209_CR14","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1055\/s-0042-121855","volume":"142","author":"L Faber","year":"2017","unstructured":"Faber L, Gleichmann U, Horstkotte D, Seggewiss H (2017) Catheter-based septal ablation for hypertrophic obstructive cardiomyopathy: long-term follow-up 1996\u20132016. Dtsch Med Wochenschr 142:276\u2013281","journal-title":"Dtsch Med Wochenschr"},{"key":"1209_CR15","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/S0735-1097(97)00508-1","volume":"31","author":"H Seggewiss","year":"1998","unstructured":"Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt HK, Strick S (1998) Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol 31:252\u2013258","journal-title":"J Am Coll Cardiol"},{"key":"1209_CR16","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s00392-005-0256-8","volume":"94","author":"L Faber","year":"2005","unstructured":"Faber L, Seggewiss H, , Gietzen FH, Kuhn H, Boekstegers P, Neuhaus L, Seipel L, Horstkotte D (2005) Catheter-based septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: follow-up results of the TASH-registry of the German Cardiac Society. Z Kardiol 94: 516 \u2013 23","journal-title":"Z Kardiol"},{"key":"1209_CR17","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/(SICI)1522-726X(199908)47:4<462::AID-CCD16>3.0.CO;2-9","volume":"47","author":"L Faber","year":"1999","unstructured":"Faber L, Seggewiss H, Ziemssen P, Gleichmann U (1999) Intraprocedural myocardial contrast echocardiography as a routine procedure in percutaneous transluminal septal myocardial ablation: detection of threatening myocardial necrosis distant from the septal target area. Catheter Cardiovasc Interv 47:462\u2013466","journal-title":"Catheter Cardiovasc Interv"},{"key":"1209_CR18","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ijcard.2006.07.179","volume":"119","author":"L Faber","year":"2007","unstructured":"Faber L, Welge D, Fassbender D, Schmidt HK, Horstkotte D, Seggewiss H (2007) Percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomopathy: managing the risk of procedure-related AV conduction disturbances. Int J Cardiol 119:163\u2013167","journal-title":"Int J Cardiol"},{"key":"1209_CR19","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1161\/01.CIR.98.22.2415","volume":"98","author":"L Faber","year":"1998","unstructured":"Faber L, Seggewiss H, Gleichmann U (1998) Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography. Circulation 98:2415\u20132421","journal-title":"Circulation"},{"key":"1209_CR20","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1161\/CIR.0b013e318223e230","volume":"124","author":"BJ Gersh","year":"2011","unstructured":"Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS,. Naidu SS, Rick A. Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW (2011) ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary. Circulation 124:2761\u20132796","journal-title":"Circulation"},{"key":"1209_CR21","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu199","volume":"35","author":"PM Elliott","year":"2014","unstructured":"Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H, McKenna WJ, Mogensen J, Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C, Rutten FH, Tillmanns C, Watkins H, members ATF (2014) 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 35:2733\u20132779","journal-title":"Eur Heart J"},{"key":"1209_CR22","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0735-1097(00)01003-2","volume":"36","author":"PM Elliott","year":"2000","unstructured":"Elliott PM, Poloniecki J, Dickie S, Sharma S, Monserrat L, Varnava A, Mahon NG, McKenna WJ (2000) Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 36:2212\u20132218","journal-title":"J Am Coll Cardiol"},{"key":"1209_CR23","first-page":"405","volume":"298","author":"BJ Maron","year":"2007","unstructured":"Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, Epstein AE, Almquist AK, Daubert JP, Lawrenz T, Boriani G, Estes NAM, Favale S, Piccininno M, Winters SL, Santini M, Betocchi S, Arribas F, Sherrid MV, Buja G, Semsarian C, Bruzzi P (2007) Implantable Cardioverter\u2013defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA 298:405\u2013412","journal-title":"JAMA"},{"key":"1209_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00392-015-0901-9","volume":"105","author":"G Frommeyer","year":"2016","unstructured":"Frommeyer G, Dechering DG, Zumhagen S, L\u00f6her A, K\u00f6be J, Eckardt L, Reinke F (2016) Long-term follow-up of subcutaneous ICD systems in patients with hypertrophic cardiomyopathy: a single-center experience. Clin Res Cardiol 105:89\u201393","journal-title":"Clin Res Cardiol"},{"key":"1209_CR25","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.cjca.2012.05.004","volume":"29","author":"C Prinz","year":"2013","unstructured":"Prinz C, Schwarz M, Ilic I, Laser KT, Lehmann R, Prinz EM, Bitter T, Vogt J, van Buuren F, Bogunovic N, Horstkotte D, Faber L (2013) Myocardial fibrosis severity on cardiac magnetic resonance imaging predicts sustained arrhythmic events in hypertrophic cardiomyopathy. Can J Cardiol 29:358\u2013363","journal-title":"Can J Cardiol"},{"key":"1209_CR26","first-page":"Suppl 1","volume":"4","author":"T Buck","year":"2009","unstructured":"Buck T, Breithardt OA, Faber L, Fehske W, Flachskampf FA, Franke A, Hagendorff A, Hoffmann R, Kruck I, K\u00fccherer H, Menzel T, Pethig K, Tiemann K, Voigt JU, Weidemann F, Nixdorff U (2009) Manual zur Durchf\u00fchrung der Echokardiographie. Clin Res Cardiol 4:Suppl 1","journal-title":"Clin Res Cardiol"},{"key":"1209_CR27","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1161\/01.CIR.58.6.1072","volume":"58","author":"DJ Sahn","year":"1978","unstructured":"Sahn DJ, DeMaria A, Kisslo J, Weyman A (1978) Recommendations regarding quantitation in m-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58:1072\u20131083","journal-title":"Circulation"},{"key":"1209_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0735-1097(92)90057-T","volume":"19","author":"JA Panza","year":"1992","unstructured":"Panza JA, Petrone RK, Fananapazir L, Maron BJ (1992) Utility of continuous wave doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 19:91\u201399","journal-title":"J Am Coll Cardiol"},{"key":"1209_CR29","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1136\/hrt.72.6_Suppl.S4","volume":"72","author":"H Watkins","year":"1994","unstructured":"Watkins H (1994) Multiple disease genes cause hypertrophic cardiomyopathy. Br Heart J 72:4\u20139","journal-title":"Br Heart J"},{"key":"1209_CR30","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1056\/NEJM199804303381802","volume":"338","author":"H Niimura","year":"1998","unstructured":"Niimura H, Bachinski LL, Sangwatanaroj S, Watkins H, Chudley AE, McKenna W, Kristinsson A, Roberts R, Sole M, Maron BJ, Seidman JG, Seidman CE (1998) Mutations in the gene for cardiac myosin-binding protein c and late-onset familial hypertrophic cardiomyopathy. N Engl J Med 338:1248\u20131257","journal-title":"N Engl J Med"},{"key":"1209_CR31","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1161\/CIRCULATIONAHA.106.644682","volume":"114","author":"MS Maron","year":"2006","unstructured":"Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, Nistri S, Cecchi F, Udelson JE, Maron BJ (2006) Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 114:2232\u20132239","journal-title":"Circulation"},{"key":"1209_CR32","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1056\/NEJM200006153422403","volume":"342","author":"P Spirito","year":"2000","unstructured":"Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ (2000) Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 342:1778\u20131785","journal-title":"N Engl J Med"},{"key":"1209_CR33","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1056\/NEJMoa021332","volume":"348","author":"MS Maron","year":"2003","unstructured":"Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, Cecchi F, Maron BJ (2003) Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 348:295\u2013303","journal-title":"N Engl J Med"},{"key":"1209_CR34","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1136\/heartjnl-2012-303339","volume":"99","author":"MK Jensen","year":"2013","unstructured":"Jensen MK, Prinz C, Horstkotte D, van Buuren F, Bitter T, Faber L, Bundgaard H (2013) Alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: low incidence of sudden cardiac death and reduced risk profile. Heart 99:1012\u20131017","journal-title":"Heart"},{"key":"1209_CR35","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1093\/eurheartj\/ehv693","volume":"37","author":"L Veselka","year":"2016","unstructured":"Veselka L, Jensen MK, Liebregts M, Januska J, Krejci J, Bartel T, Dabrowski M, Hansen PR, Almaas VM, Seggewiss H, Horstkotte D, Tomasov P, Adlova R, Bundgaard H, Steggerda R, ten Berg J, Faber L (2016) Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry. Eur Heart J 37:1517\u20131523","journal-title":"Eur Heart J"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-018-1209-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-018-1209-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-018-1209-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,17]],"date-time":"2019-02-17T03:15:12Z","timestamp":1550373312000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-018-1209-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,16]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["1209"],"URL":"https:\/\/doi.org\/10.1007\/s00392-018-1209-3","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"type":"print","value":"1861-0684"},{"type":"electronic","value":"1861-0692"}],"subject":[],"published":{"date-parts":[[2018,2,16]]},"assertion":[{"value":"13 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The study protocol was approved by the institutional review board (Ref.-#: 14\/2014) and has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}